Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012.

To access publisher's full text version of this article click on the hyperlink at the bottom of the page Epidemiology and clinical characteristics of invasive Group A streptococcal infections (IGASI) are highly variable. Long-term studies are needed to understand the interplay between epidemiol...

Full description

Bibliographic Details
Main Authors: Olafsdottir, L B, Erlendsdóttir, H, Melo-Cristino, J, Weinberger, D M, Ramirez, M, Kristinsson, K G, Gottfredsson, M
Other Authors: Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland, Landspitali Univ Hosp, Reykjavik, Iceland, Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland, Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal, NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA, Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA
Format: Article in Journal/Newspaper
Language:English
Published: Eur Centre Dis Prevention & Control 2014
Subjects:
Online Access:http://hdl.handle.net/2336/325546
Description
Summary:To access publisher's full text version of this article click on the hyperlink at the bottom of the page Epidemiology and clinical characteristics of invasive Group A streptococcal infections (IGASI) are highly variable. Long-term studies are needed to understand the interplay between epidemiology and virulence. In a population-based study of IGASI in Iceland from 1975 to 2012, 288 cases were identified by positive cultures from normally sterile body sites. Charts were reviewed retrospectively and emm-types of viable Streptococcus pyogenes isolates (n=226) determined. Comparing the first and last decade of the study period, IGASI incidence increased from 1.09 to 3.96 cases per 100,000 inhabitants per year. The most common were emm types 1 (25%), 28 (11%) and 89 (11%); emm1 strains were most likely to cause severe infections. Infections in adults were significantly more likely to be severe during the seasonal peak from January to April (risk ratio: 2.36, 95% confidence interval: 1.34–4.15). Significant seasonal variability in severity was noted among patients with diagnosis of sepsis, respiratory infection and cellulitis, with 38% of severe infections in January to April compared with 16% in other months (p<0.01). A seasonal increase in severity of IGASI suggested that generalised seasonal increase in host susceptibility, rather than introduction of more virulent strains may play a role in the pathogenesis of these potentially fatal infections. Icelandic Center for Research, Rannis/100436021 Landspitali University Hospital Science Fund